There are new technologies that allow for genetic counseling services through which the provider does not even need to get that involved in the process, said Banu Arun, MD, medical oncologist, Department of Breast Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center.
There are new technologies that allow for genetic counseling services through which the provider does not even need to get that involved in the process, said Banu Arun, MD, medical oncologist, Department of Breast Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center.
Transcript
Can you discuss the role of technology in expanding genetic counseling among patients with or at risk of developing breast cancer?
So, patients, let's start with patients with breast cancer. So, for patients with breast cancer, I think the question is, you know, what technologies we can use to do the genetic counseling. You know, you can do the traditional face-to-face counseling with the genetic counselor and the patient—that takes anywhere between 20 to 40 minutes—where pretest counseling is done and then you can order the test and you do the posttest counseling. So, that is what is widely used and what we've been doing.
But because of the increased number of patients, and the broadening testing guidelines, this might not work in especially high-volume clinics. So, what technology can use? For example, something we implemented, and I gave an example in my talk [at the San Antonio Breast Cancer Symposium], and in a heavy clinic, is to do education by video, where the patient watches, you know, a preprepared video about genetics, family history, you know, indications for testing, [and] potential results for 10 to 15 minutes. And then the provider orders the test. And when the test results are positive, either pathogenic mutation or a VUS [variant of uncertain significance], then the patient is referred for genetic counseling and is meeting with the genetic counselor. So, that's how you combine the technology with face-to-face counseling.
Now another way could be where the provider, and the counselor, is not involved at all. For example, doing web-based counseling. It is a one-way communication where the patient watches a video or a web-based presentation, and then a testing kit is sent home. The patient spits in it and then it's sent for it for genetic testing. So, there is no provider involvement. And some other technologies where a provider is not involved could include the chatbots and using some AI [artificial intelligence] technologies, but they're very new, and there are not too many studies about the outcome. But we, and other groups, are already doing some studies with using these technologies.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More